These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24363516)

  • 1. Management of portopulmonary hypertension: new perspectives.
    Mancuso L; Scordato F; Pieri M; Valerio E; Mancuso A
    World J Gastroenterol; 2013 Dec; 19(45):8252-7. PubMed ID: 24363516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Reymond M; Barbier L; Salame E; Besh C; Dumortier J; Pageaux GP; Bureau C; Dharancy S; Vanlemmens C; Abergel A; Woehl Jaegle ML; Magro P; Patat F; Laurent E; Perarnau JM
    Transplantation; 2018 Apr; 102(4):616-622. PubMed ID: 29077657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes and Survival in Moderate-severe Portopulmonary Hypertension After Liver Transplant.
    Sadd CJ; Osman F; Li Z; Chybowski A; Decker C; Henderson B; Goss KN; Hammel LL; Runo JR
    Transplantation; 2021 Feb; 105(2):346-353. PubMed ID: 32235258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
    Ashfaq M; Chinnakotla S; Rogers L; Ausloos K; Saadeh S; Klintmalm GB; Ramsay M; Davis GL
    Am J Transplant; 2007 May; 7(5):1258-64. PubMed ID: 17286619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Liver Transplant Complicated by Severe Portopulmonary Hypertension After an Initial Aborted Attempt: Case Report and Review of Treatment Options.
    Reid K; McQuillan P; Kadry Z; Janicki P; Bezinover D
    Exp Clin Transplant; 2017 Jun; 15(3):361-365. PubMed ID: 26101938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portopulmonary hypertension.
    Krowka MJ
    Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.
    Cosarderelioglu C; Cosar AM; Gurakar M; Pustavoitau A; Russell SD; Dagher NN; Gurakar A
    Exp Clin Transplant; 2016 Apr; 14(2):113-20. PubMed ID: 27015528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
    Fix OK; Bass NM; De Marco T; Merriman RB
    Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.
    Rafanan AL; Maurer J; Mehta AC; Schilz R
    Chest; 2000 Nov; 118(5):1497-500. PubMed ID: 11083710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
    Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
    Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil Monotherapy to Treat Portopulmonary Hypertension Before Liver Transplant.
    Cheng CH; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    Transplant Proc; 2019 Jun; 51(5):1435-1438. PubMed ID: 31079941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portopulmonary hypertension in liver transplant candidates.
    Bozbas SS; Bozbas H
    World J Gastroenterol; 2016 Feb; 22(6):2024-9. PubMed ID: 26877607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
    Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
    Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
    Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
    Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of paediatric portopulmonary hypertension in the modern management era: A case report of 6 patients.
    Joye R; Lador F; Aggoun Y; Farhat N; Wacker J; Wildhaber BE; Vallée JP; Hachulla AL; McLin VA; Beghetti M
    J Hepatol; 2021 Mar; 74(3):742-747. PubMed ID: 33276028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.